Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박진규 | - |
dc.date.accessioned | 2019-12-02T06:03:35Z | - |
dc.date.available | 2019-12-02T06:03:35Z | - |
dc.date.issued | 2017-11 | - |
dc.identifier.citation | KOREAN CIRCULATION JOURNAL, v. 47, no. 6, page. 877-887 | en_US |
dc.identifier.issn | 1738-5520 | - |
dc.identifier.issn | 1738-5555 | - |
dc.identifier.uri | https://e-kcj.org/DOIx.php?id=10.4070/kcj.2017.0146 | - |
dc.identifier.uri | https://repository.hanyang.ac.kr/handle/20.500.11754/116350 | - |
dc.description.abstract | Background and Objectives: The aging population is rapidly increasing, and atrial fibrillation (AF) is becoming a significant public health burden in Asia, including Korea. This study evaluated current treatment patterns and guideline adherence of AF treatment.Methods: In a prospective observational registry (COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation [CODE-AF] registry), 6,275 patients with nonvalvular AF were consecutively enrolled between June 2016 and April 2017 from 10 tertiary hospitals in Korea.Results: The AF type was paroxysmal, persistent, and permanent in 65.3%, 30.0%, and 2.9% of patients, respectively. Underlying structural heart disease was present in 11.9%. Mean CHA(2)DS(2)-VASc was 2.7 +/- 1.7. Oral anticoagulation (OAC), rate control, and rhythm control were used in 70.1%, 53.9%, and 54.4% of patients, respectively. OAC was performed in 82.7% of patients with a high stroke risk. However, antithrombotic therapy was inadequately used in 53.4% of patients with a low stroke risk. For rate control in 192 patients with low ejection fraction (<40%), ss-blocker (65.6%), digoxin (5.2%), or both (19.3%) were adequately used in 90.1% of patients; however, a calcium channel blocker was inadequately used in 9.9%. A rhythm control strategy was chosen in 54.4% of patients. The prescribing rate of class Ic antiarrythmics, dronedarone, and sotalol was 16.9% of patients with low ejection fraction.Conclusion: This study shows how successfully guidelines can be applied in the real world. The nonadherence rate was 17.2%, 9.9%, and 22.4% for stroke prevention, rate control, and rhythm control, respectively. | en_US |
dc.description.sponsorship | This study was supported by a grant from the Korean Healthcare Technology R & D project funded by the Ministry of Health and Welfare (HI15C1200). | en_US |
dc.language.iso | en_US | en_US |
dc.publisher | KOREAN SOC CARDIOLOGY | en_US |
dc.subject | Atrial fibrillation | en_US |
dc.subject | Anticoagulant agent | en_US |
dc.subject | Guidelines adherence | en_US |
dc.subject | Registry | en_US |
dc.title | A Prospective Survey of Atrial Fibrillation Management for Real-world Guideline Adherence: COmparison study of Drugs for symptom control and complication prEvention of Atrial Fibrillation (CODE-AF) Registry | en_US |
dc.type | Article | en_US |
dc.identifier.doi | 10.4070/kcj.2017.0146 | - |
dc.relation.page | 877-887 | - |
dc.relation.journal | KOREAN CIRCULATION JOURNAL | - |
dc.contributor.googleauthor | Kim, Hyeongsoo | - |
dc.contributor.googleauthor | Kim, Tae-Hoon | - |
dc.contributor.googleauthor | Cha, Myung-Jin | - |
dc.contributor.googleauthor | Lee, Jung Myung | - |
dc.contributor.googleauthor | Park, Junbeom | - |
dc.contributor.googleauthor | Park, Jin-Kyu | - |
dc.contributor.googleauthor | Kang, Ki-Woon | - |
dc.contributor.googleauthor | Shim, Jaemin | - |
dc.contributor.googleauthor | Uhm, Jae-Sun | - |
dc.contributor.googleauthor | Kim, Jun | - |
dc.relation.code | 2017008250 | - |
dc.sector.campus | S | - |
dc.sector.daehak | COLLEGE OF MEDICINE[S] | - |
dc.sector.department | DEPARTMENT OF MEDICINE | - |
dc.identifier.pid | cardiohy | - |
dc.identifier.orcid | https://orcid.org/0000-0001-7931-777X | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.